Archive · 19 Sep 2026
University of Hyderabad Patents Nanoparticle Platform for Reproductive Health
The University of Hyderabad created a tiny-particle system for delivering medicines inside the vagina.
The particles use lactoferrin, a protein found naturally in the body.
They can carry curcumin and some antiviral medicines.
Scientists are studying whether the system could help prevent infections, reduce inflammation and provide contraception.
Tests in laboratories and animals showed that the medicines could be released gradually.
The particles also showed antiviral activity over time.
They appeared compatible with Lactobacillus bacteria linked to vaginal health.
More research is needed before the system could be tested for medical use in people.
The University of Hyderabad received Indian Patent No. 602689 on September 16, 2026.
The platform uses lactoferrin nanoparticles loaded with curcumin and combined with selected antiretroviral drugs.
Researchers are investigating potential applications in STI prevention, inflammation management and contraception.
Laboratory and animal studies reported controlled drug release, sustained antiviral activity and compatibility with Lactobacillus.
Further research is needed to establish the formulations’ safety, effectiveness and clinical potential.
- Who
- Researchers at the University of Hyderabad.
- What
- They developed and patented lactoferrin nanoparticles carrying curcumin and selected antiretroviral drugs for reproductive-health research.
- When
- The patent was granted on September 16, 2026.
- Where
- The patent was granted in India; the platform is intended for local vaginal administration.
- Why
- The researchers are exploring a single platform for STI prevention, inflammation management and contraception.
- Institution
- University of Hyderabad
- Patent
- Indian Patent No. 602689
- Patent date
- September 16, 2026
- Delivery vehicle
- Lactoferrin nanoparticles
- Cargo
- Curcumin combined with efavirenz, tenofovir or dapivirine
- Potential uses
- STI prevention, inflammation management and contraception
- Study findings
- Controlled pH-dependent release, sustained antiviral activity, Lactobacillus compatibility and lower systemic absorption in animal studies